HER2-positive Early-stage Breast Cancer
2 clinical trials · Condition
◉ Watch HER2-positive Early-stage Breast Cancer
| Record | Firm | Date |
|---|---|---|
| Optimize Neoadjuvant Therapy in HER2-Positive Early-Stage Breast Cancer (NCT07402473) | Rutgers, The State University of New Jersey | 2026-03-26 |
| Paclitaxel With Trastuzumab and Lapatinib in HER2-Positive Early Stage Breast Cancer (NCT01827163) | Memorial Sloan Kettering Cancer Center | 2013-04-01 |
Track HER2-positive Early-stage Breast Cancer automatically
Every clearance here is in the API, with alerts when new ones post.